Cathie Wood continues her aggressive growth strategy, purchasing shares of Meta, Airbnb, and Beam Therapeutics as she capitalizes on recent price movements and long-term growth potential.
Cathie Wood added to Meta as the stock surged 11% on strong Muse app adoption and a Wells Fargo price target hike.
Cathie Wood bought more Airbnb despite regulatory and travel headwinds, as the company continues double-digit revenue growth.
Cathie Wood bought Beam Therapeutics after a clinical data selloff, encouraged by the accelerated approval pathway for BEAM-302.
Ark Invest CEO Cathie Wood expanded her positions in Meta Platforms, Airbnb, and Beam Therapeutics following recent market volatility. Wood leveraged Meta's 11% surge driven by Muse app adoption, Airbnb's resilient revenue growth, and a dip in Beam Therapeutics to bolster her portfolio's exposure to emerging tech and biotech.
Wood added to her Meta position following an 11% single-day stock surge, fueled by the rapid adoption of the company's new Muse AI app and an optimistic price target upgrade from Wells Fargo.
Despite a selloff following clinical data updates, Beam Therapeutics is pursuing an accelerated approval pathway for its BEAM-302 candidate, which Wood views as a strategic entry point.